Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sysmex America, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female
18 years of age or older
Diagnosed pre-surgically with T1 or T2 breast cancer and scheduled for surgery including sentinel lymph node dissection
Subjects (or the subject's legal representative) who have read, understood (to the best of their ability) and signed the informed consent form.
You may not be if
Subjects diagnosed pre-surgically with large or locally advanced (T3 \& T4) breast cancer
Pregnant subjects, confirmed by interview with either subject or treating physician
Subjects diagnosed with inflammatory breast cancer
Subjects diagnosed with ductal carcinoma in situ (DCIS) when breast conservation is to be done
Subjects with clinically suspicious, palpable axillary lymph nodes
Subjects previously treated for or previously diagnosed with another type of invasive cancer. Subjects with skin cancer (basal cell and squamous cell carcinoma) may be included, except for subjects diagnosed with melanoma
Subjects who have received pre-operative systemic therapy
Subjects who are incapable of providing written informed consent
Subjects who have been judged to be an inappropriate candidate by any medical care provider (e.g., surgeon, oncologist or pathologist).
Clareo Health | Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer
